Education
About Us
Working with TipRanks
Follow Us
Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE)
ASX:ONE
Earnings Data
Report Date
Sep 01, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.01Last Year’s EPS
-0.02Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call communicates strong commercial momentum and meaningful progress on product innovation and AI‑driven productivity—highlighted by 21% reported revenue growth (25%+ constant currency), accelerated deployments, a major Baxter partnership and clear cost‑efficiency gains (H2 OpEx down and >EUR 1.4m annualized run‑rate savings). However, material challenges remain: the company is still operating at an EBITDA loss (EUR 8.1m), cash is modest (EUR 4.6m), gross margin was compressed by revenue mix and conversion of a large Baxter/GPO pipeline and enterprise expansions are uncertain and subject to lengthy sales cycles and regulatory/capital‑spending risks. On balance, the positives (growth, partnerships, product/AI progress and OpEx improvement) outweigh the negatives, but execution and pipeline conversion will be critical to sustain the trajectory.Company Guidance
Strong Revenue Growth
Revenues increased 21% year‑on‑year in 2025 versus 2024 (driven by a EUR 1.6m increase in non‑recurring revenue and 7% growth in annual recurring revenue). On a constant currency basis growth exceeded 25%.
Improved Deployment Momentum
Deployment activity accelerated 31% in H2 2025 versus H1 2025, supporting a target to grow live endpoints ~20% in 2026 to just under 18,000 (from 14,880 at year end 2025).
Commercial Traction and New Logos
Added 18 new customer logos over the past 3 years (these 18 manage 11,631 licensed beds), creating a significant white space and an estimated 46,000 endpoint addressable opportunity across those customers.
Strategic Baxter Partnership & GPO Entry
Added to a group purchasing organization associated with one of the top 10 U.S. health systems via the Baxter partnership; Baxter pipeline includes 156+ qualified opportunities, materially expanding market access.
Product and AI Innovation Momentum
Launched a next‑generation front end and Ovie AI ecosystem (Ovie Engage, Ovie Voice, Ovie Console, Ovie Rounds) with pilots and show previews planned (ViVE/HIMSS). Ovie Console moved from concept to pilot quickly leveraging AI.
Software Development Productivity Gains
SDLC re‑design leveraging Agentic AI; the share of engineering staff reporting >15% daily time savings rose from 58% to 76% in two quarters. Targeting 4/5 maturity across key SDLC phases in 2026.
Operational Cost Efficiency
OpEx reduction in H2 2025: cash OpEx was 9% lower than H1 2025 and 13% lower than H2 2024. H2 run‑rate drop implies an annualized saving of >EUR 1.4m versus H1 2025 levels.
Gross Margin and Product Mix Transparency
Gross margin of 64% in 2025 (down 3 percentage points) was attributed to mix shift toward higher non‑recurring revenue while channel margins remain stable — management expects mid‑to‑low‑60s gross margin to hold in 2026.
Board & Leadership Strengthening
Michael Dowling (long‑time CEO of a major NY health system) joined the Board (effective 2 Dec 2025). Dr Greg Jackson appointed AI Transformation Lead to operationalize AI projects (54 identified initiatives).
Oneview Healthcare Chess Depository Interests repr 1 (AU:ONE) Earnings, Revenues Date & History
AU:ONE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AU:ONE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 11, 2026 | AU$0.33 | AU$0.30 | -7.69% |
Aug 12, 2025 | AU$0.24 | AU$0.25 | +4.17% |
Feb 25, 2025 | AU$0.34 | AU$0.34 | +1.47% |
Aug 29, 2024 | AU$0.41 | AU$0.40 | -2.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE) report earnings?
Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE) is schdueled to report earning on Sep 01, 2026, TBA (Confirmed).
What is Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE) earnings time?
Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE) earnings time is at Sep 01, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Oneview Healthcare PLC Chess Depository Interests repr 1 stock?
The P/E ratio of Oneview Healthcare Chess Depository Interests repr 1 is N/A.
What is AU:ONE EPS forecast?
AU:ONE EPS forecast for the fiscal quarter 2026 (Q2) is -0.01.